Effect of dexmedetomidine combined with sufentanil and dizosin on increasing the satisfaction of female patients after thoracoscopy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030429

Enrollment

Unknown

Registered

2020-03-01

Start date

2020-02-24

Completion date

Unknown

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thoracic tumor

Interventions

control group:sufentanil and dezocine

experimental group:dexmedetomidine combined with sufentanil and dezocine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Aged between 30 and 60 years; 2. Physical status I or II according to the American Society of Anesthesiologists; 3. Undergo Three trocars video-assisted thoracoscopic surgery,and received 48 h patient-controlled intravenous analgesia (PCIA) after surgery.

Exclusion criteria

Exclusion criteria: 1. Use of psychiatric medications and alcohol abuse; 2. With a history of Cardiovascular and liver and kidney disease; 3. Cognitive impairment; 4. Pregnant or lactating.

Design outcomes

Primary

Measure	Time frame
satisfaction;	—

Secondary

Measure	Time frame
PONV;VAS;Ramsay;	—

Countries

China

Contacts

Public ContactJingxiang Wu

Department of Anesthesiology, ShangHai Chest Hospital

Wu_jingxiang@shchest.org+86 18019370636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026